“We should be really trying to raise the profile of bladder symptoms [and] functional urology issues, and educating colleagues on how to inquire about and capture that information as effectively as possible,” says Jai Seth, MD, BSc, MSc, FRCS.
In this video, Netty Kinsella, RN, MSc, PhD, Jai Seth, MD, BSc, MSc, FRCS, and Marta Skrodzka, MD, PhD, FEBU, FECSM, FEAA, discuss major challenges that urologists and other medical professionals face when managing treatment-related side effects in patients with prostate cancer. This discussion is part of a larger forum on prostate cancer survivorship. Skrodzka is a consultant urologist and Seth is a urology consultant at St George’s University Hospital, and Kinsella is a uro-oncology nurse consultant at the Royal Marsden NHS Foundation Trust in London, United Kingdom.
The management of high-risk localized prostate cancer: Back to the future
April 5th 2024"I predict the future treatment for men with truly high-risk prostate cancer will see a fusion of what was thought to be standard local treatments combined with multimodality therapies that were initially impactful only in the more advanced disease state," writes Michael S. Cookson, MD, MMHC, FACS.